Literature DB >> 19504253

Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo.

Jason K Kim1.   

Abstract

Insulin resistance, the impaired ability of insulin to stimulate glucose utilization, is a major characteristic of type 2 diabetes. Insulin sensitivity can be measured using a variety of techniques that are commonly employed in diabetes research and care. Of these, hyperinsulinemic-euglycemic clamp is the gold-standard method to assess insulin sensitivity. The euglycemic clamp is widely used in clinics and laboratories to measure insulin action on glucose utilization in humans and animals for clinical and basic science research. Incorporation of radioactive-labeled glucose during euglycemic clamps makes it possible to measure glucose metabolism in individual organs. In recent years, euglycemic clamps have been actively performed in transgenic animal models of obesity, diabetes, and its complications, and have significantly advanced our understanding on the etiology and pathogenesis of type 2 diabetes. This chapter describes our standardized methods of the euglycemic clamp and associated surgical and biochemical procedures to measure insulin sensitivity in conscious rodents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19504253     DOI: 10.1007/978-1-59745-448-3_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  74 in total

1.  Essential nutrient supplementation prevents heritable metabolic disease in multigenerational intrauterine growth-restricted rats.

Authors:  Danielle Goodspeed; Maxim D Seferovic; William Holland; Robert A Mcknight; Scott A Summers; D Ware Branch; Robert H Lane; Kjersti M Aagaard
Journal:  FASEB J       Date:  2014-11-13       Impact factor: 5.191

2.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

3.  Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo.

Authors:  Thiago M Batista; Ruben Garcia-Martin; Weikang Cai; Masahiro Konishi; Brian T O'Neill; Masaji Sakaguchi; Jong Hun Kim; Dae Young Jung; Jason K Kim; C Ronald Kahn
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

4.  Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action.

Authors:  Lance A Thielen; Junqin Chen; Gu Jing; Omar Moukha-Chafiq; Guanlan Xu; SeongHo Jo; Truman B Grayson; Brian Lu; Peng Li; Corinne E Augelli-Szafran; Mark J Suto; Matt Kanke; Praveen Sethupathy; Jason K Kim; Anath Shalev
Journal:  Cell Metab       Date:  2020-07-28       Impact factor: 27.287

5.  Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes.

Authors:  Risheng Ye; Min Ni; Miao Wang; Shengzhan Luo; Genyuan Zhu; Robert H Chow; Amy S Lee
Journal:  J Endocrinol       Date:  2011-05-12       Impact factor: 4.286

6.  Loss of Hepatic Mitochondrial Long-Chain Fatty Acid Oxidation Confers Resistance to Diet-Induced Obesity and Glucose Intolerance.

Authors:  Jieun Lee; Joseph Choi; Ebru S Selen Alpergin; Liang Zhao; Thomas Hartung; Susanna Scafidi; Ryan C Riddle; Michael J Wolfgang
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

7.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

8.  Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance.

Authors:  Guoxiao Wang; Yingying Yu; Weikang Cai; Thiago M Batista; Sujin Suk; Hye Lim Noh; Michael Hirshman; Pasquale Nigro; Mengyao Ella Li; Samir Softic; Laurie Goodyear; Jason K Kim; C Ronald Kahn
Journal:  Diabetes       Date:  2020-08-31       Impact factor: 9.461

9.  CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance.

Authors:  Chang-An Guo; Sophia Kogan; Shinya U Amano; Mengxi Wang; Sezin Dagdeviren; Randall H Friedline; Myriam Aouadi; Jason K Kim; Michael P Czech
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-03-12       Impact factor: 4.310

10.  Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.

Authors:  Xu-qiang Nie; Huai-hong Chen; Jian-yong Zhang; Yu-jing Zhang; Jian-wen Yang; Hui-jun Pan; Wen-xia Song; Ferid Murad; Yu-qi He; Ka Bian
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.